35
from: Vivienne Hughes <[email protected]> to: GUmail <[email protected]> date: Sun, Sep 16, 2018 at 11:03 PM subject: Re: PP-Baraniuk mailed-by: griffith.edu.au Provocation Testing in CFS/ME James N. Baraniuk, MD Georgetown University, Washington DC USA

from: Vivienne Hughes to: GUmail … · 2018-12-11 · Myalgia Widespread Pain Widespread Pain Widespread Arthralgia Pain Fatigue Fatigue, Sleep Fatigue

  • Upload
    others

  • View
    7

  • Download
    1

Embed Size (px)

Citation preview

  • from: Vivienne Hughes to: GUmail date: Sun, Sep 16, 2018 at 11:03 PMsubject: Re: PP-Baraniukmailed-by: griffith.edu.au

    Provocation Testing in CFS/MEJames N. Baraniuk, MDGeorgetown University, Washington DC USA

  • Provocation Testing in CFS/ME

    James N. Baraniuk, MDGeorgetown University, Washington DC USA

    [email protected]

  • Provocation Testing in CFS/ME

    • Hypothesis:

    • Baseline symptoms, cognitive and other functions are relatively similar to normal when CFS/ME subjects are well rested.

    • It is necessary to use provocation methods to perturb body systems and induce subjective and objective evidence of dysfunction in CFS/ME compared to control subjects.

    Null Hypothesis 1:

    There are no differences between CFS/ME and control subjects.

    Null Hypothesis 2: There are substantial differences between CFS/ME and control subjects at all times that can be detected without provocations that worsen symptoms or cause exacerbations.

  • Georgetown University

    • Telephone screening for • 1994 CDC Fukuda criteria CFS/ME subjects

    • 2000 “Kansas” criteria Gulf War Illness (GWI)

    • Control subjects for sedentary activity status, and

    • Exclude major medical and psychiatric diseases.

    • All subjects complete online questionnaires to assess:• Baseline Fatigue

    • Somatic symptoms• Pain

    • Interoception

    • Psychological symptoms

    • Quality Of Life

  • Clinical Research Unit on Day 1

    • Scripted history and physical examination

    • Routine blood work

    • Serial blood work (pre-exercise baseline)

    • Dolorimetry – systemic hyperalgesia = tenderness

    • Heart Rate Variability• EKG

    • Vital signs during recumbent and standing postures

  • Chronic

    Multisymptom

    Illness (CMI) 2

    GWI

    “Kansas” 3CFS

    “Fukuda” 4FM 2010 17 FM 2011 ?? FM 1990 15

    Tenderness

    Musculoskeletal PainMyalgia Widespread

    Pain

    Widespread

    Pain

    Widespread

    PainArthralgia

    FatigueFatigue,

    Sleep

    Fatigue Fatigue Fatigue

    SleepWaking

    unrefreshed

    Waking

    unrefreshed

    Post-exertional

    malaise

    Cognition,

    Mood

    Cognition, Mood

    Neurological

    Cognition Cognition Cognition

    Depressed

    Headache Headache

    GastrointestinalSomatic

    symptoms

    Abdominal painRespiratory Sore throat

    Skin Sore lymph nodes

    ≥1 chronic symptom

    in ≥2 categories≥3 of 6 categories

    Fatigue plus

    ≥4 of 8Severity scores Severity scores

    Pain +

    Tenderness

    Defining CFS and its Differential Diagnosis

  • Chronic

    Multisymptom

    Illness (CMI) 2

    GWI

    “Kansas” 3CFS

    “Fukuda” 4FM 2010 17 FM 2011 ?? FM 1990 15

    Tenderness

    Musculoskeletal PainMyalgia Widespread

    Pain

    Widespread

    Pain

    Widespread

    PainArthralgia

    FatigueFatigue,

    Sleep

    Fatigue Fatigue Fatigue

    SleepWaking

    unrefreshed

    Waking

    unrefreshed

    Post-exertional

    malaise

    Cognition,

    Mood

    Cognition, Mood

    Neurological

    Cognition Cognition Cognition

    Depressed

    Headache Headache

    GastrointestinalSomatic

    symptoms

    Abdominal painRespiratory Sore throat

    Skin Sore lymph nodes

    ≥1 chronic symptom

    in ≥2 categories≥3 of 6 categories

    Fatigue plus

    ≥4 of 8Severity scores Severity scores

    Pain +

    Tenderness

    Defining CFS and its Differential Diagnosis

  • Chronic

    Multisymptom

    Illness (CMI) 2

    GWI

    “Kansas” 3CFS

    “Fukuda” 4FM 2010 17 FM 2011 ?? FM 1990 15

    Tenderness

    Musculoskeletal PainMyalgia Widespread

    Pain

    Widespread

    Pain

    Widespread

    PainArthralgia

    FatigueFatigue,

    Sleep

    Fatigue Fatigue Fatigue

    SleepWaking

    unrefreshed

    Waking

    unrefreshed

    Post-exertional

    malaise

    Cognition,

    Mood

    Cognition, Mood

    Neurological

    Cognition Cognition Cognition

    Depressed

    Headache Headache

    GastrointestinalSomatic

    symptoms

    Abdominal painRespiratory Sore throat

    Skin Sore lymph nodes

    ≥1 chronic symptom

    in ≥2 categories≥3 of 6 categories

    Fatigue plus

    ≥4 of 8Severity scores Severity scores

    Pain +

    Tenderness

    Defining CFS and its Differential Diagnosis

  • Center for Epidemiological Studies – Depression (CESD)

    20 items scored 0 to 3 by severity in past week

    Cut-off score ≥ 16 / 60This threshold has a 30% false positive rate [Vilagut, 2016]Sensitivity = 87% Specificity = 70%

    CESD remains the gold standard for epidemiological studies that screen populations and countries for risk of depression

    Factor Analysis: Somatic, Depressed, Anhedonia, Interpersonal

    Somatic = Fatigue, Sleep, Cognition, Effort, Bother, Talk less, AppetiteThe 4 factor scores have never been evaluated in depression or control groups

    There was a “strong relationship between the symptoms of depression as measured by the Center for Epidemiologic Studies-Depression Scale (CES-D) and fatigue, but fatigue was neither sensitive nor specific for the diagnosis of depression.”Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. PsycholMed. 1995 Sep;25(5):895-905. Review. PubMed PMID: 8588008.

  • Center for Epidemiological Studies – Depression (CESD)

    4 Factors: Somatic, Depressed, Anhedonia, Interpersonal

    24% of US population at risk for depression using total score (black) threshold of 16 / 60(NHANES & sedentary controls)

    Median

    Traditional threshold for Total CESD Score (black) = DepressionScore of 16 / 60 = 24%

  • Center for Epidemiological Studies – Depression (CESD)

    4 Factors: Somatic, Depressed, Anhedonia, Interpersonal

    94% of Depressed subjects in PROMIS studies ≥ 16 / 60

    Total CESD Score (black) threshold of 16 / 60

    Depression

  • Center for Epidemiological Studies – Depression (CESD)

    4 Factors: Somatic, Depressed, Anhedonia, InterpersonalSC CFS GWI

    High Somatic Domain Scores cause positive CESD in 54% of CFS

    Depressed Depressed

  • Center for Epidemiological Studies – Depression (CESD)

    • 4 Factors:

    • Threshold score is too low • ≥16/60 20% false positive

    • Somatic• High somatic scores drive CESD and depression in CFS

    • Depressed• Present in CFS but does not drive CESD score

    • Anhedonia• Present in CFS but does not drive CESD score

    • Interpersonal

  • Systemic Hyperalgesia in CFS, GWI and FM Females

    0%

    10%

    20%

    30%

    40%

    0 3 6 9 12

    Fre

    qu

    en

    cy

    Dolorimetry (bins of 1 kg)

    GWI n=68

    CFS n=174

    FM n=28

    SC n=133

    4.5 kg

    0

    0.2

    0.4

    0.6

    0.8

    1

    0 0.2 0.4 0.6 0.8 1

    Sen

    siti

    vity

    1 - Specificity

    GWI

    CFS

    H&P CFS (green, n=174), GWI (red, n=68), Control (black, n=133)Pain + Tenderness Fibromyalgia (1990) (yellow, n=28)

    Dolorimetry Method:Apply pressure with dolorimeter at 18 traditional FM tender points Determine pressure that causes pain Average kg Frequency distributions

  • MRI - Exercise Study to Model Exertional Exhaustion

    HYPOTHESES:

    1. CFS have depression

    2. CFS have tenderness (systemic hyperalgesia)

    3. Submaximal exercise on DAY 1 reduced VO2 on DAY 2

    4. Submaximal exercise on DAY 1 postural tachycardia in 1/3rd

    5. Exercise worsens orthostatic intolerance

    6. MRI before exercise on DAY 1 will show good brain function

    MRI after exercise on DAY 2 will show bad brain function

    7. Cerebrospinal fluid contains CFS biomarkers

    MRI DAY 1 DAY 2 MRI LPQ H&P

  • MRI - Exercise Study to Model Exertional Exhaustion

    MRI DAY 1 DAY 2 MRI LPQ H&P

    Ceiling vs

    FloorEffects

    FunctionalDisordersMigraine

    MRI: 3T Seimens TrimTrio, 32 element head coil, new PRISMABrain anatomy – voxel based morphometryMolecular spectroscopyResting state scan for Resting State NetworksCognitive Task n-Back working memory task

    Attention = 0-back = “See a letter. Press a button.”Working memory = 2-back = “See a string of letters…

    Submaximal test: Does exercise on Day 1 cause a decrease in exercise on DAY 2?

    “Brain” biomarkers

  • MRI - Exercise Study to Model Exertional Exhaustion

    Background:

    GWI Submaximal exercise on DAY 1 postural tachycardia in 1/3rd

    Stress Test Activated Reversible Tachycardia = START = 25%

    No postural tachycardia before exercise

    Postural tachycardia after exercise

    ≥ 2 time points with ΔHR ≥30 bpm after exercise

    ΔHR = Standing – Recumbent

    No ΔHR = STOPP = 62% of CFS

    POTS = 13% of CFS = GWI = Control = Literature Standing Up

    MRI DAY 1 DAY 2 MRI LPQ H&P

  • Orthostatic Problems

    • Orthostatic Intolerance

    • Symptoms

    • Dizziness, Lightheaded

    • Orthostatic Instability

    • Change in heart rate with posture

    • Change in autonomic tone• Vagal – Parasympathetic to slow

    down the heart• Sympathetic to speed up the

    heart

    • Results are biased from Heads Up Tilt Table testing• High false positive rate• Not physiological

  • Dizziness Before Exercise

    Control CFS

    Recumbent Standing Recumbent Standing

    CFS had significantly more Dizziness than Controls while supine and standing. Dizziness Score > 2/20 reported in 9/25 Controls and 33/39 CFS (FET, p

  • Dizziness After Exercise

    Postural Orthostatic Tachycardia

    Exercise-Induced Postural

    Tachycardia

    Postural Orthostatic Tachycardia

    Exercise-Induced Postural

    Tachycardia

    Exercise increased Dizziness in 22/39 CFSPOTS did not explain Dizziness in CFS

    Exercise caused symptoms that could not be explained by postural tachycardia

  • Dizziness After Exercise

    Dizziness While Lying Down in 41% CFSExercise increased Dizziness in 22/39 CFS (56%)

    POTS did not explain Dizziness before exercisePostural Tachycardia did not explain the increased Dizziness after exercise (85%)Receiver Operating Characteristics defined Dizziness > 2 / 20

    No Orthostatic Intolerance (No OI) = 28%Postural Orthostatic Intolerance = Standing = 31% Persistent Orthostatic Intolerance = Recumbent & Standing = 41%

    Recumbent Standing

    Control CFS

  • Recumbent Dizziness in CFS

    • Recumbent Dizziness in CFS in 41%• Persistent Orthostatic Intolerance (symptoms)

    • Dizziness gets worse in 85% of CFS• Component of Post-Exertional Malaise?

    • Dizziness is not related to postural tachycardia• Orthostatic instability (heart rate)

    • Postural tachycardia is related to decreased parasympathetic tone • Decreased vagal messages from the brain stem allow the heart to speed up• NULL HYPOTHESIS: Autonomic dysfunction (orthostatic instability) is not the

    cause of dizziness and orthostatic intolerance

    • HYPOTHESIS: It is all in your head (Vestibular, Brain stem, other?)

  • MRI - Exercise Study to Model Exertional Exhaustion

    HYPOTHESES:

    1. CFS have depression

    2. CFS have tenderness (systemic hyperalgesia)

    3. Submaximal exercise on DAY 1 reduced VO2 on DAY 2

    4. Submaximal exercise on DAY 1 postural tachycardia in 1/3rd of CFS

    5. Exercise worsens orthostatic intolerance (symptoms)

    6. MRI before exercise on DAY 1 will show good brain function

    MRI after exercise on DAY 2 will show bad brain function

    MRI DAY 1 DAY 2 MRI LPQ H&P

  • MRI - Exercise Study to Model Exertional Exhaustion

    HYPOTHESES:

    1. CFS have depression

    2. CFS have tenderness (systemic hyperalgesia)

    3. Submaximal exercise on DAY 1 reduced VO2 on DAY 2

    4. Submaximal exercise on DAY 1 postural tachycardia in 1/3rd

    5. Exercise worsens orthostatic intolerance

    6. MRI before exercise on DAY 1 will show good brain function

    MRI after exercise on DAY 2 will show bad brain function

    7. Cerebrospinal fluid contains CFS biomarkers

    MRI DAY 1 DAY 2 MRI LPQ H&P

  • Cerebrospinal Fluid for Cytokines

  • Cerebrospinal Fluid for Metabolomics

    • Untargeted “Discovery”• 17 positive mode and 22 negative mode peaks between sedentary control,

    CFS and GWI groups at Nonexercise and Post-Exercise• None identified in databases or by hand sequencing

    • Targeted Biocrates 180 analytes• 2 significantly different

    • C5-OH (C3-DC-M)• PC ae C44:4

    Pearson Correlations

    Positive Mode

    Negative Mode

  • Unknowns in LC-MS-MS

    Positive Mode: Pooled Nonexercise (white) vs. Post-exercise (grey)Acrolein suspected Positive Mode @ 456 sec

    18 Negative Mode Peaks at 249 sec

    e.g. M460T249nm

    Distinguish CFS from GWI in Nonexercise specimens

    Mean ± SD

  • No exercise Post-exerciseTargeted Metabolomics

    Control

    CFS

    GWI

    GWISTART

    GWISTOPP

    Control

    Exercise

  • Lumbar Puncture Cerebrospinal fluid miRNA

    DNA genome & genes

    pre-mRNA

    Spliceosome & Processing

    Mature mRNA miRNA~22 ntd

    Mature mRNAmiRNA

    miRNA binds mRNAmRNA destroyedNo proteinTranslate mRNA

    into protein

    miRNAs fine tuneprotein expression

    In general, miRNAs were reduced

    after exercise

  • sc0>SC SC>sc0 gwi0>cfs0 gwi0>START START>gwi0 gwi0>STOPP cfs0>CFS

    33 targets 224 targets targets? 23 targets 36 targets 48 targets 61 targets

    miR-328

    miR-608

    miR-425-3p

    miR-30d-5p

    miR-204-5p

    miR-1180

    miR-328

    miR-608

    miR-200a-5p

    miR-93-3p

    let-7i-5p

    miR-425-3p

    miR-328

    miR-608

    miR-200a-5p

    miR-93-3p

    let-7i-5p

    miR-328

    miR-608

    miR-200a-5p

    miR-93-3p

    miR-92a-3p

    Lumbar Puncture Cerebrospinal fluid miRNA DIANA for gene targets

    No Exercisesc0 = sedentary controls

    cfs0 = CFS no exercisegwi0 = GWI with no exercise

    Post Exercise – After DAY2 ExericseSC = sedentary controls

    CFS = CFSSTART = GWI Stress Test Activated Reverisible TachycardiaSTOPP = GWI Stress Test Originated Phantom Perception

    In general, miRNAs were equivalent within No Exercise and Post-Exercise specimensmiRNAs were higher before exercise and (cfs0>CFS, gwi0>START, gwi0>STOPP)

    [except for sc0>SC and SC>sc0]

  • # GO Category p-value Genes #

    miRNA

    1 nucleoplasm (GO:0005654) 8.19E-05 8 4

    2 ribonucleoprotein complex

    (GO:0030529)

    0.00067 5 4

    3 organelle (GO:0043226) 0.00067 16 4

    4 mitotic cell cycle (GO:0000278) 0.0020 4 3

    5 cytosol (GO:0005829) 0.0020 9 4

    6 cellular component assembly

    (GO:0022607)

    0.0047 6 4

    7 gene expression (GO:0010467) 0.0055 4 4

    8 RNA binding (GO:0003723) 0.0056 7 4

    9 cellular nitrogen compound

    metabolic process (GO:0034641)

    0.0056 10 4

    10 exoribonuclease activity,

    producing 5'-phosphomonoesters

    (GO:0016896)

    0.0093 1 3

    11 cytoplasmic ribonucleoprotein

    granule (GO:0036464)

    0.0093 2 4

    12 DNA replication initiation

    (GO:0006270)

    0.0095 2 3

    13 ATP-dependent chromatin

    remodeling (GO:0043044)

    0.0095 2 4

    # KEGG pathway p-value #

    genes

    #

    miRNA

    1 Fatty acid

    biosynthesis (hsa00061)

    3.12E-36 1 2

    2 Fatty acid

    metabolism (hsa01212)

    2.46E-13 2 2

    3 Adherens junction (hsa04520) 0.000256 7 4

    4 Lysine degradation (hsa00310) 0.000485 4 3

    5 Transcriptional misregulation

    in cancer (hsa05202)

    0.000515 7 4

    6 Viral myocarditis (hsa05416) 0.003162 7 4

    7 Cell cycle (hsa04110) 0.005299 11 4

    Combinations of miRNAs DIANA Intersection of Pathways Weighted Targets

  • # Modules of target proteins with linkers Top pathway for each moduleCy0 ACTB, CDC42, ELK4, FASN, FYN, IGF1R, IQGAP1, PTPRJ, SETD7, ZNF703

    (Linkers: CCT8, CSNK2A2, CTNNB1, MAPK3, STAT3)Adherens junction

    Cy1 BAG6, DYRK1A, EWSR1, H3F3B, KMT2D, SCD, SIN3A(Linkers: EP300, HIST1H4A, RXRA)

    Transcriptional misregulation in cancer

    Cy2 DDX5, HNRNPC, NCL, PCBP2, PRPF8, SCARB2, TCF3(Linker: HSPA8)

    Processing of Capped Intron-Containing Pre-mRNA (Reactome)

    Cy3 ASH1L, DCP2, DYNC1H1, SPOPL, TGFBR1, (Linkers: SUFU, UBC)

    Beta5 beta6 beta7 and beta8 integrin cell surface interactions (NCI PID)

    Cy4 CCND2, CCNE2, MCM7, RB1 Cell cycle (KEGG)

    miRNA DIANA target genes pathways plausible druggable targets and drugs

    Ingenuity Pathway Analysis (IPA)

    Cytoscapemodules

  • MRI - Exercise Study to Model Exertional Exhaustion

    HYPOTHESES:

    1. CFS have depression

    2. CFS have tenderness (systemic hyperalgesia)

    3. Submaximal exercise on DAY 1 reduced VO2 on DAY 2

    4. Submaximal exercise on DAY 1 postural tachycardia in 1/3rd of CFS

    5. Exercise worsens orthostatic intolerance

    6. MRI before exercise on DAY 1 will show good brain function

    MRI after exercise on DAY 2 will show bad brain function

    7. Cerebrospinal fluid will contain CFS biomarkers

    MRI DAY 1 DAY 2 MRI LPQ H&P

  • Provocation Testing in CFS/ME

    • Common Data Elements to share data between sites

    • Evidence-based definitions for CFS, ME, SEID, GWI, FM, depression

    • Systemic hyperalgesia in CFS and GWI

    • Post-Exertional Malaise / Exertional Exhaustion• Model reveals pathophysiological changes induced by exertion• Unclear if VO2max is changed or diagnostic

    • Orthostatic Intolerance (symptoms) vs. Orthostatic Instability (HR)• Recumbent Dizziness “Persistent Orthostatic Intolerance”• Exercise makes orthostatic symptoms worse• POTS and START (ΔHR) are not relevant to symptoms in the broad group of CFS

    • Cerebrospinal Fluid• Metabolomics analytes are significantly changed but not identified• miRNA Informatics Infer pathways Mechanisms?

  • Thank you for the invitation, opportunity,

    and fellowship

    James N. Baraniuk MD

    Georgetown University, Washington DC

    [email protected]